Sands Capital Alternatives, LLC
Source: SEC Form 13F · as of Mar 2026Sands Capital Alternatives, LLC holds 4 biotech & pharma companies tracked by BioSniper, totaling $24.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$24.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for BioAge Labs, Inc. (BIOA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BIOABioAge Labs, Inc. | 786,353 | $13.8M |
| TARSTarsus Pharmaceuticals, Inc. | 85,000 | $6.0M |
| TSHATaysha Gene Therapies, Inc. | 724,873 | $3.2M |
| CADLCandel Therapeutics, Inc. | 405,837 | $2.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.